CD8A and neoplasm: Of note, CD38hi CD8+ T cells reinvigorated by ICI have been detected, using mass cytometry, in tumor and peripheral blood samples from NSCLC patients, where they correlated with improved responses to PD-1 inhibitors [90, 91].